601 related articles for article (PubMed ID: 34339582)
1. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
Chen F; Shi Q; Pei F; Vogt A; Porritt RA; Garcia G; Gomez AC; Cheng MH; Schurdak ME; Liu B; Chan SY; Arumugaswami V; Stern AM; Taylor DL; Arditi M; Bahar I
Mol Syst Biol; 2021 Aug; 17(8):e10239. PubMed ID: 34339582
[TBL] [Abstract][Full Text] [Related]
2. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
5. The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications.
Singh RD; Barry MA; Croatt AJ; Ackerman AW; Grande JP; Diaz RM; Vile RG; Agarwal A; Nath KA
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166322. PubMed ID: 34920080
[TBL] [Abstract][Full Text] [Related]
6. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
7. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
[TBL] [Abstract][Full Text] [Related]
8. 17β-estradiol reduces SARS-CoV-2 infection in vitro.
Lemes RMR; Costa AJ; Bartolomeo CS; Bassani TB; Nishino MS; Pereira GJDS; Smaili SS; Maciel RMB; Braconi CT; da Cruz EF; Ramirez AL; Maricatto JT; Janini LMR; Prado CM; Stilhano RS; Ureshino RP
Physiol Rep; 2021 Jan; 9(2):e14707. PubMed ID: 33463909
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.
Grau-Expósito J; Perea D; Suppi M; Massana N; Vergara A; Soler MJ; Trinite B; Blanco J; García-Pérez J; Alcamí J; Serrano-Mollar A; Rosado J; Falcó V; Genescà M; Buzon MJ
PLoS Pathog; 2022 Jan; 18(1):e1010171. PubMed ID: 35025963
[TBL] [Abstract][Full Text] [Related]
10. Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
Prabhakara C; Godbole R; Sil P; Jahnavi S; Gulzar SE; van Zanten TS; Sheth D; Subhash N; Chandra A; Shivaraj A; Panikulam P; U I; Nuthakki VK; Puthiyapurayil TP; Ahmed R; Najar AH; Lingamallu SM; Das S; Mahajan B; Vemula P; Bharate SB; Singh PP; Vishwakarma R; Guha A; Sundaramurthy V; Mayor S
PLoS Pathog; 2021 Jul; 17(7):e1009706. PubMed ID: 34252168
[TBL] [Abstract][Full Text] [Related]
11. Identification of potent small molecule inhibitors of SARS-CoV-2 entry.
Mediouni S; Mou H; Otsuka Y; Jablonski JA; Adcock RS; Batra L; Chung DH; Rood C; de Vera IMS; Rahaim R; Ullah S; Yu X; Getmanenko YA; Kennedy NM; Wang C; Nguyen TT; Hull M; Chen E; Bannister TD; Baillargeon P; Scampavia L; Farzan M; Valente ST; Spicer TP
SLAS Discov; 2022 Jan; 27(1):8-19. PubMed ID: 35058179
[TBL] [Abstract][Full Text] [Related]
12. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
13. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal.
Tanimoto K; Hirota K; Fukazawa T; Matsuo Y; Nomura T; Tanuza N; Hirohashi N; Bono H; Sakaguchi T
Sci Rep; 2021 Aug; 11(1):16629. PubMed ID: 34404832
[TBL] [Abstract][Full Text] [Related]
15. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
Terracciano R; Preianò M; Fregola A; Pelaia C; Montalcini T; Savino R
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430309
[TBL] [Abstract][Full Text] [Related]
16. Anti-SARS-CoV-2 Viral Activity of Sweet Potato Trypsin Inhibitor via Downregulation of TMPRSS2 Activity and ACE2 Expression In Vitro and In Vivo.
Jiang WP; Deng JS; Yu CC; Lin JG; Huang GJ
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892254
[TBL] [Abstract][Full Text] [Related]
17. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
18. Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry.
Ao Z; Chan M; Ouyang MJ; Olukitibi TA; Mahmoudi M; Kobasa D; Yao X
PLoS One; 2021; 16(6):e0251649. PubMed ID: 34106944
[TBL] [Abstract][Full Text] [Related]
19. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P
Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263
[TBL] [Abstract][Full Text] [Related]
20. Repositioning of histamine H
Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]